FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to a therapeutic agent used for a graft-versus-host disease (GVHD), which contains an interleukin-6 (IL-6) receptor inhibitor as an active ingredient, wherein the interleukin-6 (IL-6) receptor inhibitor is an IL-6 receptor antibody. The declared method is also used for the graft-versus-host disease, which comprises administering the IL-6 receptor antibody.
EFFECT: invention provides inhibiting the developing graft-versus-host disease.
4 cl, 1 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENTS FOR SUPPRESSING TRANSPLANTED ISLAND DAMAGE FOLLOWING ISLAND TRANSPLANTATION | 2006 |
|
RU2446826C2 |
| AGENT FOR CARDIOPATHY | 2006 |
|
RU2450830C2 |
| CHRONIC REJECTION INHIBITOR | 2008 |
|
RU2450829C2 |
| THERAPEUTIC AGENT FOR MESOTHELIOMA | 2004 |
|
RU2392967C2 |
| PROPHYLACTIC DRUG FOR VASCULITIS | 2004 |
|
RU2379054C2 |
| THERAPEUTIC AGENT FOR MESOTHELIOMA | 2004 |
|
RU2554942C2 |
| MEDICATION FOR TREATMENT OF RHEUMATOID ARTHRITIS | 2010 |
|
RU2524152C2 |
| METHOD OF OBTAINING PREPARATION OF ANTIBODY AGAINST IL-18 OR ITS ANTIGEN-BINDING PART (VERSIONS) | 2009 |
|
RU2514657C2 |
| HUMAN VISTA ANTIBODIES AND THEIR APPLICATION | 2017 |
|
RU2746994C2 |
| THERAPEUTIC AGENT FOR ITCHING | 2008 |
|
RU2596397C2 |
